1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Applications
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4. Impact of COVID-19
on Global Lower Respiratory Tract Therapeutics Market
5. Voice of Customer
6.
Global Lower Respiratory Tract Therapeutics Market Outlook
6.1. Market Size &
Forecast
6.1.1. By Value
6.2. Market Share &
Forecast
6.2.1. By Disease Type (Asthma, COPD, Pneumonia, Tuberculosis, Bronchitis, Others)
6.2.2. By Drug Class (Antibiotics, Non-Steroidal Anti-Inflammatory
Drugs, Cough Suppressants, Nasal Decongestants, Others)
6.2.3. By Route of Administration (Oral, Parenteral, Others)
6.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centres, Others)
6.2.5. By Region
6.2.6. By Company (2022)
6.3. Market Map
7.
Asia Pacific Lower Respiratory Tract Therapeutics Market Outlook
7.1. Market Size &
Forecast
7.1.1. By Value
7.2. Market Share &
Forecast
7.2.1. By Disease Type
7.2.2. By Drug Class
7.2.3. By Route of Administration
7.2.4. By End User
7.2.5. By Country
7.3. Asia Pacific:
Country Analysis
7.3.1. China Lower
Respiratory Tract Therapeutics Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Disease Type
7.3.1.2.2.
By Drug Class
7.3.1.2.3.
By Route of Administration
7.3.1.2.4.
By End User
7.3.2. India Lower
Respiratory Tract Therapeutics Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Disease Type
7.3.2.2.2.
By Drug Class
7.3.2.2.3.
By Route of Administration
7.3.2.2.4.
By End User
7.3.3. Australia Lower
Respiratory Tract Therapeutics Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Disease Type
7.3.3.2.2.
By Drug Class
7.3.3.2.3.
By Route of Administration
7.3.3.2.4.
By End User
7.3.4. Japan Lower
Respiratory Tract Therapeutics Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Disease Type
7.3.4.2.2.
By Drug Class
7.3.4.2.3.
By Route of Administration
7.3.4.2.4.
By End User
7.3.5. South Korea Lower
Respiratory Tract Therapeutics Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Disease Type
7.3.5.2.2.
By Drug Class
7.3.5.2.3.
By Route of Administration
7.3.5.2.4.
By End User
8.
Europe Lower Respiratory Tract Therapeutics Market Outlook
8.1. Market Size &
Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Disease Type
8.2.2. By Drug Class
8.2.3. By Route of Administration
8.2.4. By End User
8.2.5. By Country
8.3. Europe: Country
Analysis
8.3.1. France Lower
Respiratory Tract Therapeutics Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Disease Type
8.3.1.2.2.
By Drug Class
8.3.1.2.3.
By Route of Administration
8.3.1.2.4.
By End User
8.3.2. Germany Lower
Respiratory Tract Therapeutics Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Disease Type
8.3.2.2.2.
By Drug Class
8.3.2.2.3.
By Route of Administration
8.3.2.2.4.
By End User
8.3.3. Spain Lower
Respiratory Tract Therapeutics Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Disease Type
8.3.3.2.2.
By Drug Class
8.3.3.2.3.
By Route of Administration
8.3.3.2.4.
By End User
8.3.4. Italy Lower
Respiratory Tract Therapeutics Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Disease Type
8.3.4.2.2.
By Drug Class
8.3.4.2.3.
By Route of Administration
8.3.4.2.4.
By End User
8.3.5. United Kingdom Lower
Respiratory Tract Therapeutics Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Disease Type
8.3.5.2.2.
By Drug Class
8.3.5.2.3.
By Route of Administration
8.3.5.2.4.
By End User
9.
North America Lower Respiratory Tract Therapeutics Market Outlook
9.1. Market Size &
Forecast
9.1.1. By Value
9.2. Market Share &
Forecast
9.2.1. By Disease Type
9.2.2. By Drug Class
9.2.3. By Route of Administration
9.2.4. By End User
9.2.5. By Country
9.3. North America:
Country Analysis
9.3.1. United States Lower
Respiratory Tract Therapeutics Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Disease Type
9.3.1.2.2.
By Drug Class
9.3.1.2.3.
By Route of Administration
9.3.1.2.4.
By End User
9.3.2. Mexico Lower
Respiratory Tract Therapeutics Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Disease Type
9.3.2.2.2.
By Drug Class
9.3.2.2.3.
By Route of Administration
9.3.2.2.4.
By End User
9.3.3. Canada Lower
Respiratory Tract Therapeutics Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Disease Type
9.3.3.2.2.
By Drug Class
9.3.3.2.3.
By Route of Administration
9.3.3.2.4.
By End User
10.
South America Lower Respiratory Tract Therapeutics Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Disease Type
10.2.2. By Drug Class
10.2.3. By Route of Administration
10.2.4. By End User
10.2.5. By Country
10.3.
South America: Country Analysis
10.3.1. Brazil Lower
Respiratory Tract Therapeutics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Disease Type
10.3.1.2.2.
By Drug Class
10.3.1.2.3.
By Route of Administration
10.3.1.2.4.
By End User
10.3.2. Argentina Lower
Respiratory Tract Therapeutics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Disease Type
10.3.2.2.2.
By Drug Class
10.3.2.2.3.
By Route of Administration
10.3.2.2.4.
By End User
10.3.3. Colombia Lower
Respiratory Tract Therapeutics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Disease Type
10.3.3.2.2.
By Drug Class
10.3.3.2.3.
By Route of Administration
10.3.3.2.4.
By End User
11.
Middle East and Africa Lower Respiratory Tract
Therapeutics Market Outlook
11.1.
Market Size & Forecast
11.1.1. By Value
11.2.
Market Share & Forecast
11.2.1. By Disease Type
11.2.2. By Drug Class
11.2.3. By Route of Administration
11.2.4. By End User
11.2.5. By Country
11.3.
MEA: Country Analysis
11.3.1. South Africa Lower
Respiratory Tract Therapeutics Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1.
By Disease Type
11.3.1.2.2.
By Drug Class
11.3.1.2.3.
By Route of Administration
11.3.1.2.4.
By End User
11.3.2. Saudi Arabia Lower
Respiratory Tract Therapeutics Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1.
By Disease Type
11.3.2.2.2.
By Drug Class
11.3.2.2.3.
By Route of Administration
11.3.2.2.4.
By End User
11.3.3. UAE Lower
Respiratory Tract Therapeutics Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1.
By Disease Type
11.3.3.2.2.
By Drug Class
11.3.3.2.3.
By Route of Administration
11.3.3.2.4.
By End User
12. Market Dynamics
12.1.
Drivers
12.2.
Challenges
13. Market Trends &
Developments
13.1.
Recent Developments
13.2.
Product Launches
13.3.
Mergers & Acquisitions
14. Global Lower
Respiratory Tract Therapeutics Market: SWOT Analysis
15.
Porter’s Five Forces Analysis
15.1.
Competition in the Industry
15.2.
Potential of New Entrants
15.3.
Power of Suppliers
15.4.
Power of Customers
15.5.
Threat of Substitute Product
16. PESTLE Analysis
17. Competitive
Landscape
17.1.
F. Hoffman – La Roche Ltd
17.1.1. Business Overview
17.1.2. Company Snapshot
17.1.3. Products &
Services
17.1.4. Financials (In case
of listed companies)
17.1.5. Recent Developments
17.2.
Teva Pharmaceutical Industries Ltd.
17.3.
Sanofi S.A
17.4.
Pfizer Inc.
17.5.
GSK plc
17.6.
Novartis AG
17.7.
AstraZeneca
17.8.
Johnson & Johnson
17.9.
Sun Pharmaceutical Industries Ltd.
17.10.
Merck & Co., Inc
18.
Strategic
Recommendations
19. About Us & Disclaimer